![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 22, 14175-14178, Aug, 1991
L Ala-Kokko, J Hyland, C Smith, KI Kivirikko, SA Jimenez and DJ Prockop
Department of Biochemistry and Molecular Biology, Jefferson Institute of Molecular Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.
Expression in a recombinant system has been difficult to obtain for any of the major fibrillar collagens that require processing by eight or more post-translational enzymes. Here, two DNA constructs were designed so that the promoter region of the gene for the pro-alpha 1(I) chain of human type I procollagen drove expression of the human type II procollagen gene in mouse NIH 3T3 cells, a culture line that normally synthesizes type I procollagen but not any cartilage-specific protein such as type II procollagen. Both constructs were expressed as both mRNA and protein. In clones expressing the construct at high levels, the steady-state levels of mRNA and the production of type II procollagen were comparable to the mRNA levels and production of type I procollagen from the endogenous mouse genes. Comparison of clones containing the two constructs demonstrated that sequences extending 80 base pairs beyond the major polyadenylation signal of the gene are not in themselves sufficient for correct termination and 3' processing of RNA transcripts. The results strongly suggest that specific sequences present in a downstream 3.5-kilobase SphI/SphI fragment determine the termination of the transcription. Of special importance is that the system will make it possible to examine the consequences of mutations in the human type II procollagen gene on the processing of RNA transcripts and on the functional properties of the protein simply by using the genomic DNA from leukocytes or other non-cartilaginous sources.
This article has been cited by other articles:
![]() |
N. Louneva, B. Saitta, D. J. Herrick, and S. A. Jimenez Transcriptional Inhibition of Type I Collagen Gene Expression in Scleroderma Fibroblasts by the Antineoplastic Drug Ecteinascidin 743 J. Biol. Chem., October 10, 2003; 278(41): 40400 - 40407. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fertala, L. Ala-Kokko, R. Wiaderkiewicz, and D. J. Prockop Collagen II Containing a Cys Substitution for Arg-alpha 1-519. HOMOTRIMERIC MONOMERS CONTAINING THE MUTATION DO NOT ASSEMBLE INTO FIBRILS BUT ALTER THE SELF-ASSEMBLY OF THE NORMAL PROTEIN J. Biol. Chem., March 7, 1997; 272(10): 6457 - 6464. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lamberg, T. Helaakoski, J. Myllyharju, S. Peltonen, H. Notbohm, T. Pihlajaniemi, and K. I. Kivirikko Characterization of Human Type III Collagen Expressed in a Baculovirus System J. Biol. Chem., May 17, 1996; 271(20): 11988 - 11995. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Sokolov, L. Ala-Kokko, R. Dhulipala, M. Arita, J. S. Khillan, and D. J. Prockop Tissue-specific Expression of the Gene for Type I Procollagen (COL1A1) in Transgenic Mice J. Biol. Chem., April 21, 1995; 270(16): 9622 - 9629. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ghayor, J.-F. Herrouin, C. Chadjichristos, L. Ala-Kokko, M. Takigawa, J.-P. Pujol, and P. Galera Regulation of Human COL2A1 Gene Expression in Chondrocytes. IDENTIFICATION OF C-Krox-RESPONSIVE ELEMENTS AND MODULATION BY PHENOTYPE ALTERATION J. Biol. Chem., August 25, 2000; 275(35): 27421 - 27438. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |